Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-10
12:41 pm
Purchase
13GIntellia Therapeutics, Inc.
NTLA
ARK Investment Management LLC9,420,782
11.2%
1,503,900increase
(+19.00%)
View
2023-02-09
11:22 am
Purchase
13GIntellia Therapeutics, Inc.
NTLA
VANGUARD GROUP INC7,810,226
9.28%
1,367,871increase
(+21.23%)
View
2023-02-09
11:18 am
Sale
13GIntellia Therapeutics, Inc.
NTLA
FMR LLC2,421,952
2.879%
-1,455,820decrease
(-37.54%)
View
2023-01-25
10:36 am
Purchase
13GIntellia Therapeutics, Inc.
NTLA
BlackRock Inc.
BLK
7,254,921
8.7%
1,634,545increase
(+29.08%)
View
2022-02-14
06:05 am
Sale
13GIntellia Therapeutics, Inc.
NTLA
Nikko Asset Management Americas Inc.2,753,903
3.7%
-2,350,459decrease
(-46.05%)
View
2022-02-11
4:06 pm
Purchase
13GIntellia Therapeutics, Inc.
NTLA
REGENERON PHARMACEUTICALS INC.
REGN
3,702,995
4.98%
925,218increase
(+33.31%)
View
2022-02-10
08:17 am
Purchase
13GIntellia Therapeutics, Inc.
NTLA
VANGUARD GROUP INC6,442,355
8.66%
1,311,158increase
(+25.55%)
View
2022-02-09
2:38 pm
Purchase
13GIntellia Therapeutics, Inc.
NTLA
ARK Investment Management LLC7,916,882
10.64%
274,430increase
(+3.59%)
View
2022-02-09
09:19 am
Purchase
13GIntellia Therapeutics, Inc.
NTLA
FMR LLC3,877,772
5.21%
3,719,166increase
(+2344.91%)
View
2022-02-04
06:05 am
Sale
13GIntellia Therapeutics, Inc.
NTLA
Sumitomo Mitsui Trust Holdings Inc.2,753,903
3.7%
-2,350,459decrease
(-46.05%)
View
2022-02-03
4:41 pm
Purchase
13GIntellia Therapeutics, Inc.
NTLA
BlackRock Inc.
BLK
5,620,376
7.6%
567,531increase
(+11.23%)
View
2021-11-26
3:23 pm
Sale
13GIntellia Therapeutics, Inc.
NTLA
ARK Investment Management LLC7,642,452
10.4%
-3,549,218decrease
(-31.71%)
View
2021-02-16
4:33 pm
Purchase
13GIntellia Therapeutics, Inc.
NTLA
ARK Investment Management LLC11,191,670
17.4%
2,450,238increase
(+28.03%)
View
2021-02-11
4:24 pm
Sale
13GIntellia Therapeutics, Inc.
NTLA
Nikko Asset Management Americas Inc.5,104,362
7.94%
-318,856decrease
(-5.88%)
View
2021-02-10
11:03 am
Purchase
13GIntellia Therapeutics, Inc.
NTLA
VANGUARD GROUP INC5,131,197
7.98%
1,606,998increase
(+45.60%)
View
2021-02-05
06:10 am
Sale
13GIntellia Therapeutics, Inc.
NTLA
Sumitomo Mitsui Trust Holdings Inc.5,104,362
7.94%
-318,856decrease
(-5.88%)
View
2021-01-29
09:56 am
Purchase
13GIntellia Therapeutics, Inc.
NTLA
BlackRock Inc.
BLK
5,052,845
8.6%
1,407,615increase
(+38.62%)
View
2021-01-22
4:59 pm
Sale
13DIntellia Therapeutics, Inc.
NTLA
Novartis Institutes for BioMedical Research Inc.2,176,148
3.7%
-2,176,147decrease
(-50.00%)
View
2020-12-09
06:01 am
Sale
13GIntellia Therapeutics, Inc.
NTLA
Sumitomo Mitsui Trust Holdings Inc.5,423,218
9.18%
-1,755,302decrease
(-24.45%)
View
2020-12-08
4:26 pm
Sale
13GIntellia Therapeutics, Inc.
NTLA
Nikko Asset Management Americas Inc.5,423,218
9.18%
-1,755,302decrease
(-24.45%)
View
Goto 0, 1, 2, Next